Eva María Galán‐Moya

Author

Also Known As

E M Galan Moya, E M Galan-Moya, E M Galán-Moya, E. Galán-Moya, E. M. Galán-Moya, E.M. Galan-Moya, E.M. Galán-Moya, EM Galán-Moya, Eva Galan-Moya, Eva M Galan-Moya

108

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Castilla-La Mancha Hospital General Universitario de Albacete Centro de Investigación Biomédica en Red de Cáncer Centro de Investigación del Cáncer Instituto de Investigación Biomédica de Salamanca

About

Eva María Galán‐Moya is an author at University of Castilla-La Mancha specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	978
2	Public Health	2	2	74
3	Social Sciences	2	2	74
4	Engineering	1	1	57
5	Biomedical Engineering	1	1	57

Eva María Galán‐Moya

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma Lucas Treps, Sébastien Edmond, Elizabeth Harford‐Wright, Oncogene Vascular PermeabilityNeuro-oncologyAngiogenesisGliomaExtracellular Microvesicles	2015	127
Secreted factors from brain endothelial cells maintain glioblastoma stem‐like cell expansion through the mTOR pathway Eva María Galán‐Moya, Armelle Le Guelte, Evelyne Lima‐Fernandes, EMBO Reports Neuro-oncologyAngiogenesisDevelopmental BiologyGliomaMedicine	2011	119
RETRACTED ARTICLE: P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance Miguel Ángel de la Cruz-Morcillo, María Llanos Valero, Juan Luis Callejas‐Valera, Oncogene Tumor BiologyMitophagyCell AutophagyMedicineReceptor Tyrosine Kinase	2011	115
Glioblastoma Cell-Secreted Interleukin-8 Induces Brain Endothelial Cell Permeability via CXCR2 Julie Dwyer, Jagoda K. Hebda, Armelle Le Guelte, PLoS ONE Endothelial PermeabilityImmunologyHigh-grade GliomasGliomaTumor Biology	2012	100
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer María del Mar Noblejas‐López, Cristina Nieto‐Jiménez, Miguel Burgos, Journal of Experimental & Clinical Cancer Research	2019	93
Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation Armelle Le Guelte, Eva María Galán‐Moya, Julie Dwyer, Journal of Cell Science	2012	80
Differential Proteomic Analysis of Human Glioblastoma and Neural Stem Cells Reveals HDGF as a Novel Angiogenic Secreted Factor Cécile Thirant, Eva María Galán‐Moya, Luiz Gustavo Dubois, Stem Cells High-grade GliomasCancer BiologyGliomaTumor BiologyNeuro-oncology	2012	79
Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome María del Mar Noblejas‐López, Cristina Nieto‐Jiménez, Sara Morcillo García, OncoImmunology HistocompatibilityKm PlotterBreast OncologyMhc ClassHla Immunogenetics	2019	79
Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer Enrique Niza, María del Mar Noblejas‐López, Iván Bravo, Nanomaterials NanoparticlesEngineeringEnhanced DeliveryBiomedical EngineeringTumor Biology	2019	57
Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer Ana Alcaráz-Sanabria, Cristina Nieto‐Jiménez, Verónica Corrales‐Sánchez, Molecular Cancer Therapeutics	2017	55

Page 1